(Q44529078)

3 December 2017

Dopamine neurotoxicity: age-dependent behavioral and histological effects (English)

1 reference

3 December 2017

1 reference

1 reference

Ippolita Cantuti-Castelvetri

series ordinal

1

1 reference

PubMed ID

12885577

3 December 2017

Barbara Shukitt-Hale

series ordinal

2

1 reference

PubMed ID

12885577

3 December 2017

James A Joseph

series ordinal

3

1 reference

3 December 2017

1 September 2003

1 reference

3 December 2017

Neurobiology of Aging

1 reference

3 December 2017

24

1 reference

3 December 2017

5

1 reference

3 December 2017

697-706

1 reference

Dopamine neurotoxicity in cortical neurons.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Oxidants, antioxidants, and the degenerative diseases of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Influence of age on hypoxia/reoxygenation-induced DNA fragmentation and bcl-2, bcl-xl, bax and fas in the rat heart and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Parkinson's disease is not one disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Differential effect of dopamine catabolism and uptake inhibition on dopamine-induced calcium dysregulation and viability loss

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

An improved cupric-silver method for impregnation of axonal and terminal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Locomotion of aged rats: relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Integrated evaluation of central nervous system lesions: stains for neurons, astrocytes, and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Reactive oxygen species and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Role of free radicals in aging and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Enzymatic oxidation of dopamine: the role of prostaglandin H synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Diverse pre- and post-synaptic expression of m1-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Levodopa neurotoxicity: experimental studies versus clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Receptor- and age-selective effects of dopamine oxidation on receptor-G protein interactions in the striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Selective cross-activation/inhibition of second messenger systems and the reduction of age-related deficits in the muscarinic control of dopamine release from perifused rat striata.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Copernicus revisited: amyloid beta in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Age differences in sensitivity to H2O2- or NO-induced reductions in K(+)-evoked dopamine release from superfused striatal slices: reversals by PBN or Trolox

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Increased sensitivity to oxidative stress and the loss of muscarinic receptor responsiveness in senescence

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Striatal trophic activity is reduced in the aged rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

An endogenous dopaminergic neurotoxin: implication for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Toxic and protective effects of L-dopa on mesencephalic cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

An introduction to the free radical hypothesis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Oxidation of dopamine in the presence of cysteine: characterization of new toxic products

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Psychomotor effects of dopamine infusion under decreased glutathione conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Spatial learning and memory deficits induced by dopamine administration with decreased glutathione.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Psychomotor and spatial memory performance in aging male Fischer 344 rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Does levodopa accelerate Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Differential thionin block staining of nerve cells and fibers for paraffin-embedded material in mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

Fasting-induced depletion of glutathione in the aging mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900186-0

7 January 2021

10.1016/S0197-4580(02)00186-0

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12885577